Non-invasive prenatal testing for management of haemolytic disease of the fetus and newborn induced by maternal alloimmunisation

CA Hyland, H O'Brien, RL Flower… - Transfusion and Apheresis …, 2020 - Elsevier
Anti-D immunoglobulin prophylaxis reduces the risk of RhD negative women becoming
alloimmunised to the RhD antigen and is a major preventative strategy in reducing the …

Distribution of maternal red cell antibodies and the risk of severe alloimmune haemolytic disease of the foetus in a Chinese population: a cohort study on prenatal …

S Li, Z He, Y Luo, Y Ji, G Luo, Q Fang, Y Gao - BMC pregnancy and …, 2020 - Springer
Background Haemolytic disease of the foetus and newborn (HDFN) is the most common
aetiology of haemolytic anaemia and hyperbilirubinaemia in foetuses and neonates. Studies …

[PDF][PDF] 抗-M 抗体致噬血细胞综合征患者迟发性溶血性输血反应1 例

董雅静, 苏瑞蕊, 张霁云, 李小飞 - 临床血液学杂志, 2021 - lcxy.whuhzzs.com
A58yearsoldmanwasdiagnosedwithhemop…. Hereceivedbloodtransfusion foranemia.
Aftertransfusion, erythrocytetransfusionwasineffectiveandbilir…. Thedirectantibody test …

A single‐center, retrospective analysis of 17 cases of hemolytic disease of the fetus and newborn caused by anti‐M antibodies

Y He, W Gao, Y Li, C Xu, Q Wang - Transfusion, 2023 - Wiley Online Library
Objective We aimed to summarize the laboratory findings and clinical features of hemolytic
disease of the fetus and newborn (HDFN). Methods We retrospectively analyzed the data for …

[HTML][HTML] The power of digital PCR in fetal blood group genotyping: a review

CA Hyland, H O'Brien, EC McGowan, AJ Perros… - Annals of …, 2023 - aob.amegroups.org
There is a clinical need to determine the fetal blood group status for pregnant women who
present with clinically significant red cell antibodies to optimize perinatal care. Non-invasive …

[PDF][PDF] 妊娠期抗-M 抗体检出率及妊娠结局分析

陈君, 宋艳, 叶珍, 王淑平 - 临床血液学杂志, 2022 - lcxy.whuhzzs.com
目的: 探讨妊娠期不规则抗体检测中抗-M 抗体的检出率及其对孕产妇妊娠结局的影响,
以提高临床对抗-M 抗体的认识, 增加孕产妇妊娠成功率. 方法: 应用NEO 全自动血型分析仪进行 …

Red blood cell alloimmunization prevalence and hemolytic disease of the fetus and newborn in Israel: A retrospective study

N Rahimi‐Levene, J Chezar, V Yahalom… - …, 2020 - Wiley Online Library
Background Hemolytic disease of the fetus and newborn (HDFN) is a severe form of anemia
caused by maternal antibodies against fetal red blood cells (RBC) that can cause …

Hyporegenerative anemia in anti‐M‐associated hemolytic disease of the fetus

S Li, Z He, C Mo, Y Ji, Y Luo, Q Fang, Y Gao - Transfusion, 2021 - Wiley Online Library
Background The anti‐M antibody can lead to hemolytic disease of the fetus and newborn
(HDFN) and adverse fetal outcomes, especially in the Asian population. However, fetal …

Feasibility for non‐invasive prenatal fetal blood group and platelet genotyping by massively parallel sequencing: A single test system for multiple atypical red cell …

EC McGowan, H O'Brien, ME Sarri… - British Journal of …, 2024 - Wiley Online Library
Non‐invasive prenatal tests (NIPT) to predict fetal red cell or platelet antigen status for
alloimmunised women are provided for select antigens. This study reports on massively …

Fetal and neonatal outcome in severe alloimmunization managed with intrauterine transfusion: 18-year experience in a tertiary referral hospital in China

W Pan, H Wu, J Chen, X Mo, H Wang, Q Fang… - Frontiers in …, 2023 - frontiersin.org
Background Hemolytic disease of the fetus and newborn (HDFN) due to red cell
alloimmunization, is an important cause of fetal and neonatal morbidity and mortality …